Retatrutide 20mg

Retatrutide is an advanced, synthetic triple-agonist peptide designed to interact with the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. Engineered to an analytical-grade purity profile of 99%, this compound is a sophisticated reagent utilized in pioneering endocrinological and metabolic research. It is a critical tool for investigators exploring the complex, synergistic signaling mechanisms involved in multireceptor activation and metabolic homeostasis in vitro.

The product is supplied as a secure, vacuum-sealed lyophilized powder to protect its precise triple-agonist molecular structure from environmental degradation and ensure high-level consistency for sensitive experimental assays. To preserve its biochemical integrity, the vial must be kept under continuous cold-chain storage at 2–8°C. In strict compliance with regulatory laboratory standards, this Retatrutide reagent is distributed exclusively for laboratory research and in vitro experimentation only. It is explicitly not approved, intended, or safe for human or veterinary therapeutic use, clinical administration, or personal dietary or medical consumption.